Patent US4093716A successfully refreshed from Google Patents.
US4093716A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compositions containing 5-amino-5-deoxythymidine and pharmaceutically acceptable salts thereof
Assignee: Research Corp
•
Filing: 1977-04-28
•
Granted: 1978-06-06
•
Expires: 1997-04-28
Abstract
Abstract The known compound 5'-amino-5'-deoxythymidine and the pharmaceutically acceptable acid addition salts thereof are potent inhibitors of herpes simplex virus and compositions containing one or more of them are therapeutically useful.
Inventors
- 👤 Tai-Shun Lin
- 👤 H. William Prusoff
- 👤 David C. Ward
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 11:14
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; A; A61; A61P; A61P31/00; A61P31/12
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
42 words
A pharmaceutical composition containing an effective amount of a compound for treating herpes simplex virus infection in mammals, said compound being selected from the group consisting of 5'-amino-5'-deoxythymidine and the pharmaceutically acceptable acid addition salts thereof together with a pharmaceutically acceptable carrier.
Claim 2
Dependent Claim
42 words
A pharmaceutical composition containing an effective amount of a compound for treating herpes simplex virus infection in mammals, said compound being selected from the group consisting of 5'-amino-5'-deoxythymidine and the pharmaceutically acceptable acid addition salts thereof together with a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
7 words
A composition of claim 1 containing 5'-amino-5'-deoxythymidine.
Claim 4
Independent Claim
56 words
A method of treating a herpes simplex virus infection in a host mammal afflicted with such infection which comprises administering to the said host an amount of a compound which is effective for treating a herpes simplex virus infection, said compound being selected from the group consisting of 5'-amino-5'-deoxythymidine and the pharmaceutically acceptable acid salts thereof.
Claim 5
Independent Claim
56 words
A method of treating a herpes simplex virus infection in a host mammal afflicted with such infection which comprises administering to the said host an amount of a compound which is effective for treating a herpes simplex virus infection, said compound being selected from the group consisting of 5'-amino-5'-deoxythymidine and the pharmaceutically acceptable acid salts thereof.
Claim 6
Dependent Claim
11 words
A method as in claim 3 wherein the compound is 5'-amino-5'-deoxythymidine.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-06-05 | 1981-12-05 | 1982-06-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-06-05 | 1985-12-05 | 1986-06-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-06-05 | 1989-12-05 | 1990-06-06 | $7700.00 | Window Closed / Lapsed |